Activin and Inhibin

Epsilon-V1-2 (ε-V1-2), a PKCε-derived peptide, is a selective PKCε inhibitor. Epsilon-V1-2 inhibits the translocationof PKCε , but not α-, β-, and δPKCIn VitroEpsilon-V1-2 (ε-V1-2), a PKCε-derived peptide containing the site for its specific

Epsilon-V1-2 (ε-V1-2), a PKCε-derived peptide, is a selective PKCε inhibitor. Epsilon-V1-2 inhibits the translocationof PKCε , but not α-, β-, and δPKCIn VitroEpsilon-V1-2 (ε-V1-2), a PKCε-derived peptide containing the site for its specific

Epsilon-V1-2 (ε-V1-2), a PKCε-derived peptide, is a selective PKCε inhibitor. Epsilon-V1-2 inhibits the translocationof PKCε , but not α-, β-, and δPKCIn VitroEpsilon-V1-2 (ε-V1-2), a PKCε-derived peptide containing the site for its specific

EPZ-719 is a novel and potent SETD2 inhibitor ( IC 50 = 0.005 μM) with a high selectivity over other histone methyltransferases.Form:Solid.

EPZ-719 is a novel and potent SETD2 inhibitor ( IC 50 = 0.005 μM) with a high selectivity over other histone methyltransferases.Form:Solid.

EPZ004777 hydrochloride is a potent, selective DOT1L inhibitor with an IC 50 of 0.4 nM.In VitroEPZ004777 demonstrates potent, concentration-dependent inhibition of DOT1L enzyme activity with an IC 50 of 400±100 pM. EPZ004777 displays remarkable

EPZ004777 hydrochloride is a potent, selective DOT1L inhibitor with an IC 50 of 0.4 nM.In VitroEPZ004777 demonstrates potent, concentration-dependent inhibition of DOT1L enzyme activity with an IC 50 of 400±100 pM. EPZ004777 displays remarkable

EPZ-011989 trifluoroacetate is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ-011989 trifluoroacetate has inhibitory inhibition for EZH2 with a K i value of &lt:3 nM. EPZ-011989 trifluoroacetate shows

EPZ-011989 trifluoroacetate is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ-011989 trifluoroacetate has inhibitory inhibition for EZH2 with a K i value of &lt:3 nM. EPZ-011989 trifluoroacetate shows

EPZ-011989 trifluoroacetate is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ-011989 trifluoroacetate has inhibitory inhibition for EZH2 with a K i value of &lt:3 nM. EPZ-011989 trifluoroacetate shows

EPZ020411 is a selective inhibitor of PRMT6 with an IC 50 of 10 nM, has &gt:10 folds selectivity for PRMT6 over PRMT1 and PRMT8 . EPZ020411 can be used for the research of cancerIn VitroEPZ020411 (0-20 μM: 24 h) decreases H3R2 methylation in A375

EPZ020411 is a selective inhibitor of PRMT6 with an IC 50 of 10 nM, has &gt:10 folds selectivity for PRMT6 over PRMT1 and PRMT8 . EPZ020411 can be used for the research of cancerIn VitroEPZ020411 (0-20 μM: 24 h) decreases H3R2 methylation in A375